Medicines (File Photo)
Amid the increasing cost of some basic commodities in the Philippines, the prices of medicines in the country remain stable, the Department of Health (DOH) said.
This was based on the recent monitoring of medicine prices in December last year, said DOH Officer-in-Charge M
What's #TRENDING? Understanding and documenting industry analysis bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.
Credit should be given to the Duterte administration which pushed to reality the imposition of maximum drug prices for medicines. The policy benefits all consumers and sectors whether poor and rich. In legal parlance, the price regulation is a valid exercise of the State’s police power, parens patri
Published May 6, 2021, 8:00 AM
The domestic pharmaceutical and healthcare industry has been forecasted to rebound this year with a 5-6 percent growth from a negative 11 percent in 2020, but initial results are not actually looking good, according to a top industry leader.
Dr. Beaver Tamesis, president of the Pharmaceutical and Healthcare Association of the Philippines (PHAP) said at the Wednesday Roundtable at Lido the P270-billion industry was initially projected to grow 5-6 percent this year.
Photo credit: https://www.phap.org.ph/uhc/
“Given the pandemic, the initial forecast last year for 2021 is we may return to some growth of 5 to 6 percent,” he said. But Tamesis said that the way things are going on, “It’s not looking very good. We had to go into lockdown again, limited patients admitted to hospitals and capacity at 40 percent. Still a touch and go for the rest of the year,” he said.